Literature DB >> 6965307

Synergistic genetic defect in B-lymphocyte function. I. Defective responses to B-cell stimulants and their genetic basis.

C Bona, J J Mond, W E Paul.   

Abstract

CBA/N female mice, which express an X-linked defect in B-lymphocyte function, were mated with C3H/HeJ male mice, which are unresponsive to lipopolysaccharide (LPS). The resulting F1 hybrid females were mated to C3H/HeJ males. Approximately one-half of the backcross (BC.1) males obtained from this mating expressed a more profound immunologic defect than either of the parental strains. Spleen cells from these mice were unresponsive to a series of B-cell mitogens including LPS prepared from Escherichia coli K235 and from E. coli 0111:B4, lipoprotein mitogen from E. coli, and Nocardia water-soluble mitogen (NWSM). They failed to give in vitro antibody responses to the thymus-independent type 2 (TI-2) antigen trinophenylated Ficoll and most were unresponsive to the TI-1 antigens trinitrophenylated Brucella abortus, trinitrophenylated LPS, and trinitrophenylated NWSM. This synergistic defect in B-lymphocyte function depended on the presence of the CBA/N xid gene but the critical gene(s) from the C3H strain was not the defective Lps gene (Lpsd). These mice should provide a valuable tool for the elucidation of B-lymphocyte ontogeny, heterogeneity, and function.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6965307      PMCID: PMC2185770          DOI: 10.1084/jem.151.1.224

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  The genetic mapping of a defective LPS response gene in C3H/HeJ mice.

Authors:  J Watson; K Kelly; M Largen; B A Taylor
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

2.  B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens.

Authors:  A Ahmed; I Scher; S O Sharrow; A H Smith; W E Paul; D H Sachs; K W Sell
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

Review 3.  Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes.

Authors:  D E Mosier; I M Zitron; J J Mond; A Ahmed; I Scher; W E Paul
Journal:  Immunol Rev       Date:  1977       Impact factor: 12.988

4.  Isolation of mitogenic and adjuvant active fractions from various species of Nocardiae.

Authors:  R Ciorbaru; A Adam; J F Petit; E Lederer; C Bona; L Chedid
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

5.  Development of B-lymphocyte colony-forming cells in foetal mouse tissues.

Authors:  G R Johnson; D Metcalf; J W Wilson
Journal:  Immunology       Date:  1976-06       Impact factor: 7.397

6.  Thymus-independent antigens: the preparation of covalent, hapten-ficoll conjugates.

Authors:  J K Inman
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

7.  Defective colony formation by B lymphocytes from CBA/N and C3H/HeJ mice.

Authors:  P W Kincade
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

8.  X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells.

Authors:  I Scher; A Ahmed; D M Strong; A D Steinberg; W E Paul
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

9.  Abnormal ratio of membrane immunoglobulin classes in mice with an X-linked B-lymphocyte defect.

Authors:  F D Finkelman; A H Smith; I Scher; W E Paul
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

10.  Identification of a B-cell surface structure involved in antigen-dependent triggering: absence of this structure on B cells from CBA/N mutant mice.

Authors:  B Huber; R K Gershon; H Cantor
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

View more
  8 in total

1.  Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes.

Authors:  David A Fruman; Gregory Z Ferl; Sam S An; Amber C Donahue; Anne B Satterthwaite; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

2.  Isotype profiles of anti-influenza antibodies in mice bearing the xid defect.

Authors:  M A Reale; C A Bona; J L Schulman
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

3.  Btk dosage determines sensitivity to B cell antigen receptor cross-linking.

Authors:  A B Satterthwaite; H Cheroutre; W N Khan; P Sideras; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  A sensitized genetic system for the analysis of murine B lymphocyte signal transduction pathways dependent on Bruton's tyrosine kinase.

Authors:  A B Satterthwaite; F Willis; P Kanchanastit; D Fruman; L C Cantley; C D Helgason; R K Humphries; C A Lowell; M Simon; M Leitges; A Tarakhovsky; T F Tedder; R Lesche; H Wu; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

5.  Establishment of an inbred line of mice that express a synergistic immune defect precluding in vitro responses to type 1 and type 2 antigens, B cell mitogens, and a number of T cell-derived helper factors.

Authors:  J J Mond; G Norton; W E Paul; I Scher; F D Finkelman; S House; M Schaefer; P K Mongini; C Hansen; C Bona
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

6.  Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways.

Authors:  A B Satterthwaite; C A Lowell; W N Khan; P Sideras; F W Alt; O N Witte
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

7.  Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation.

Authors:  U D Bajpai; K Zhang; M Teutsch; R Sen; H H Wortis
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

8.  Lack of mature B cells in nude mice with X-linked immune deficiency.

Authors:  H H Wortis; L Burkly; D Hughes; S Roschelle; G Waneck
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.